Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palladyne AI (PDYN) Cash & Equivalents (2020 - 2025)

Historic Cash & Equivalents for Palladyne AI (PDYN) over the last 6 years, with Q3 2025 value amounting to $27.4 million.

  • Palladyne AI's Cash & Equivalents rose 2828.68% to $27.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.4 million, marking a year-over-year increase of 2828.68%. This contributed to the annual value of $31.2 million for FY2024, which is 3478.54% up from last year.
  • As of Q3 2025, Palladyne AI's Cash & Equivalents stood at $27.4 million, which was up 2828.68% from $20.1 million recorded in Q2 2025.
  • Palladyne AI's Cash & Equivalents' 5-year high stood at $239.1 million during Q3 2021, with a 5-year trough of $14538.0 in Q2 2021.
  • Over the past 5 years, Palladyne AI's median Cash & Equivalents value was $31.8 million (recorded in 2024), while the average stood at $70.3 million.
  • As far as peak fluctuations go, Palladyne AI's Cash & Equivalents soared by 89028382.17% in 2022, and later plummeted by 7083.45% in 2023.
  • Quarter analysis of 5 years shows Palladyne AI's Cash & Equivalents stood at $217.1 million in 2021, then tumbled by 63.46% to $79.3 million in 2022, then tumbled by 70.83% to $23.1 million in 2023, then surged by 34.79% to $31.2 million in 2024, then dropped by 12.27% to $27.4 million in 2025.
  • Its Cash & Equivalents was $27.4 million in Q3 2025, compared to $20.1 million in Q2 2025 and $10.1 million in Q1 2025.